Bioluminescent Kinase Profiling Systems For Characterizing Small Molecule Kinase Inhibitors
Poster Aug 07, 2017
Hicham Zegzouti, Jacquelyn Hennek, Tracy Worzella, Monse Contreras, Cristopher Cowan and Said Goueli
In order to profile compounds against a broad panel of kinases, in-house profiling requires rigorous kinase assay development. Most importantly, it requires an optimization for each kinase in the panel, which can be costly and time consuming. On the other hand, outsourcing kinase profiling is fraught with obstacles such as requirements of agreements, long timelines and lack of control over the whole process. Thus, a profiling system with simple and rapid in-house implementation would obviate such logistical inconveniences and concerns.
We created new kinase profiling systems based on the luminescent ADP-Glo™ kinase assay platform. The kinase profiling systems have the following features and advantages:
• Set of kinases organized by kinase families, presented in easy to use multi-well strips, and standardized for optimal kinase activity.
• The strip system provides flexible kinase inhibitor profiling, as each strip can be used to profile compounds at a single dose or used for a dose response against 8 kinases at once.
• Easily automated with fast and simple reaction assembly.
The data generated with this novel set-up are concordant with published inhibitor potency profiles produced by radioactivity assays. Using this technology we created profiles for 16 small molecule compounds that are approved for different cancers and inflammatory diseases. Medicinal chemists and chemical biologists can easily adopt this novel approach for regular in-house kinase inhibitor profiling and gain more control over the data for fast progression into developing lead compounds.
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
Human papillomavirus (HPV) vaccine rates continue to be low in the United States. Young women ages 18-26 years are eligible for catch-up vaccination but previous research shows that relationships status and percieved risk may be barriers to HPV vaccination. The purpose of this quantitative study was to assess the association between relationship status and perceived risk for HPV among young adult women.READ MORE
This abstract discusses three cases of pediatric heart transplant patients who suffered from parvovirus (B19) infection. Of these patients, two ( B & C) responded well to standard intravenous Ig therapy. Patient A however, did not respond to standard treatment and was begun on subcutaneous Ig, which effectively diminished his viral load. Thus, subcutaneous Ig infusions might serve as a second line treatment for transplant patients with parvovirus who do not respond well to the standard approach.READ MORE